Medical condition
Cell Therapy
Cell Therapy is a medical condition tracked by NovaPharmaNews. Browse the latest pharmaceutical industry coverage and developments.
Latest Cell Therapy news
Cencora-Kite Agreement: A New Era for CAR T-cell Therapy Commercialization
The Cencora-Kite agreement marks a significant shift in CAR T-cell therapy commercialization, leveraging Cencora's distribution expertise to streamline patient access and reduce operational complexities. This collaboration aims to accelerate the delivery of critical therapies like Yescarta and Tecartus.
Expression Therapeutics Receives FDA Fast Track and Rare Pediatric Disease Designations for Hemophilia A Stem Cell Therapy
Expression Therapeutics gains dual FDA designations for investigational autologous stem cell therapy targeting hemophilia A, advancing to Phase 2 trials.
Miracell's SMART M-CELL Stem Cell Therapy Shows Cognitive Improvement in Severe Alzheimer's Patients
Miracell reports positive Phase 2 results for SMART M-CELL CD34+ stem cell therapy showing cognitive improvement in moderate to severe Alzheimer's patients.
FDA Approves First Cell Therapy for Treatment-Resistant MS
The FDA has approved AHSCT, the first cell therapy for treatment-resistant multiple sclerosis, marking a significant advancement in MS treatment options.
UCB Acquires Neurona Therapeutics for NRTX-1001 Epilepsy Cell Therapy in $XXX Million Deal
UCB announces acquisition of Neurona Therapeutics and lead epilepsy cell therapy NRTX-1001, currently in Phase I/II trials for treatment-resistant epilepsy patients.
FDA Approves Omisirge: New Allogeneic Stem Cell Therapy for Hematologic Cancers
The FDA has approved Omisirge, an innovative allogeneic stem cell therapy designed to treat hematologic cancers, marking a significant advancement in cancer care.
CAR-T Cell Therapy Advancements and FDA Regulatory Pathways 2024
Discover the latest advancements in CAR-T cell therapy for cancer, including FDA regulatory pathways and their impact on treatment options in 2024.